Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Updated risk models demonstrate low risk of symptomatic radionecrosis following stereotactic radiosurgery for brain metastases.

Peng L, Grimm J, Gui C, Shen CJ, Redmond KJ, Sloan L, Hazell S, Moore J, Huang E, Spoleti N, Laub W, Quon H, Bettegowda C, Lim M, Kleinberg LR.

Surg Neurol Int. 2019 Mar 15;10:32. doi: 10.4103/sni.sni_303_18. eCollection 2019.

2.

Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.

Ajani JA, D'Amico TA, Bentrem DJ, Chao J, Corvera C, Das P, Denlinger CS, Enzinger PC, Fanta P, Farjah F, Gerdes H, Gibson M, Glasgow RE, Hayman JA, Hochwald S, Hofstetter WL, Ilson DH, Jaroszewski D, Johung KL, Keswani RN, Kleinberg LR, Leong S, Ly QP, Matkowskyj KA, McNamara M, Mulcahy MF, Paluri RK, Park H, Perry KA, Pimiento J, Poultsides GA, Roses R, Strong VE, Wiesner G, Willett CG, Wright CD, McMillian NR, Pluchino LA.

J Natl Compr Canc Netw. 2019 Jul 1;17(7):855-883. doi: 10.6004/jnccn.2019.0033.

PMID:
31319389
3.

A prospective evaluation of whole brain volume loss and neurocognitive decline following hippocampal-sparing prophylactic cranial irradiation for limited-stage small-cell lung cancer.

Gui C, Chintalapati N, Hales RK, Voong KR, Sair HI, Grimm J, Duhon M, Kleinberg LR, Vannorsdall TD, Redmond KJ.

J Neurooncol. 2019 Sep;144(2):351-358. doi: 10.1007/s11060-019-03235-7. Epub 2019 Jul 13.

PMID:
31302830
4.

Phase II Study of Preoperative Chemoradiotherapy with Oxaliplatin, Infusional 5-Fluorouracil, and Cetuximab Followed by Postoperative Docetaxel and Cetuximab in Patients with Adenocarcinoma of the Esophagus: A Trial of the ECOG-ACRIN Cancer Research Group (E2205).

Gibson MK, Catalano P, Kleinberg LR, Staley CA 3rd, Montgomery EA, Jimeno A, Song WF, Mulcahy MF, Leichman LP, Benson AB 3rd.

Oncologist. 2019 Jun 21. pii: theoncologist.2018-0750. doi: 10.1634/theoncologist.2018-0750. [Epub ahead of print]

PMID:
31227647
5.

Assessing the Effectiveness of Systemic Therapy after Stereotactic Radiosurgery on Cancer Recurrence and All-Cause Mortality.

Al-Khindi T, Shen CJ, Peng L, Redmond KJ, Lim M, Kleinberg LR, Bettegowda C.

World Neurosurg. 2019 Sep;129:e572-e581. doi: 10.1016/j.wneu.2019.05.218. Epub 2019 May 31.

PMID:
31158536
6.
7.

Initial SRS for Patients With 5 to 15 Brain Metastases: Results of a Multi-Institutional Experience.

Hughes RT, Masters AH, McTyre ER, Farris MK, Chung C, Page BR, Kleinberg LR, Hepel J, Contessa JN, Chiang V, Ruiz J, Watabe K, Su J, Fiveash JB, Braunstein S, Chao S, Attia A, Ayala-Peacock DN, Chan MD.

Int J Radiat Oncol Biol Phys. 2019 Aug 1;104(5):1091-1098. doi: 10.1016/j.ijrobp.2019.03.052. Epub 2019 Apr 6.

PMID:
30959122
8.

Widely metastatic IDH1-mutant glioblastoma with oligodendroglial features and atypical molecular findings: a case report and review of current challenges in molecular diagnostics.

Romo CG, Palsgrove DN, Sivakumar A, Elledge CR, Kleinberg LR, Chaichana KL, Gocke CD, Rodriguez FJ, Holdhoff M.

Diagn Pathol. 2019 Feb 9;14(1):16. doi: 10.1186/s13000-019-0793-5. Review.

9.

Contrasting impact of corticosteroids on anti-PD-1 immunotherapy efficacy for tumor histologies located within or outside the central nervous system.

Maxwell R, Luksik AS, Garzon-Muvdi T, Hung AL, Kim ES, Wu A, Xia Y, Belcaid Z, Gorelick N, Choi J, Theodros D, Jackson CM, Mathios D, Ye X, Tran PT, Redmond KJ, Brem H, Pardoll DM, Kleinberg LR, Lim M.

Oncoimmunology. 2018 Sep 6;7(12):e1500108. doi: 10.1080/2162402X.2018.1500108. eCollection 2018.

10.

Re-irradiation for malignant glioma: Toward patient selection and defining treatment parameters for salvage.

Shen CJ, Kummerlowe MN, Redmond KJ, Martinez-Gutierrez JC, Usama SM, Holdhoff M, Grossman SA, Laterra JJ, Strowd RE, Kleinberg LR.

Adv Radiat Oncol. 2018 Jul 10;3(4):582-590. doi: 10.1016/j.adro.2018.06.005. eCollection 2018 Oct-Dec.

11.

Outcomes of Metastatic Brain Lesions Treated with Radioactive Cs-131 Seeds after Surgery: Experience from One Institution.

Xia Y, Mashouf LA, Baker BR, Maxwell R, Bettegowda C, Redmond KJ, Kleinberg LR, Lim M.

Cureus. 2018 Jul 30;10(7):e3075. doi: 10.7759/cureus.3075.

12.

Adjuvant radiotherapy and outcomes of presumed hemorrhagic melanoma brain metastases without malignant cells.

Xia Y, Mashouf LA, Maxwell R, Peng LC, Lipson EJ, Sharfman WH, Bettegowda C, Redmond KJ, Kleinberg LR, Lim M.

Surg Neurol Int. 2018 Jul 26;9:146. doi: 10.4103/sni.sni_140_18. eCollection 2018.

13.

Phase II study of rituximab given in conjunction with standard chemotherapy in primary central nervous system lymphoma (PCNSL): a trial of the ECOG-ACRIN cancer research group (E1F05).

Swinnen LJ, O'Neill A, Imus PH, Gujar S, Schiff D, Kleinberg LR, Advani RH, Dunbar EM, Moore D, Grossman SA.

Oncotarget. 2017 Nov 6;9(1):766-773. doi: 10.18632/oncotarget.22332. eCollection 2018 Jan 2.

14.

A prospective evaluation of hippocampal radiation dose volume effects and memory deficits following cranial irradiation.

Ma TM, Grimm J, McIntyre R, Anderson-Keightly H, Kleinberg LR, Hales RK, Moore J, Vannorsdall T, Redmond KJ.

Radiother Oncol. 2017 Nov;125(2):234-240. doi: 10.1016/j.radonc.2017.09.035. Epub 2017 Nov 8.

PMID:
29128167
15.

Long-term Treatment Response and Patient Outcomes for Vestibular Schwannoma Patients Treated with Hypofractionated Stereotactic Radiotherapy.

Patel MA, Marciscano AE, Hu C, Jusué-Torres I, Garg R, Rashid A, Francis HW, Lim M, Redmond KJ, Rigamonti D, Kleinberg LR.

Front Oncol. 2017 Sep 4;7:200. doi: 10.3389/fonc.2017.00200. eCollection 2017.

16.

Long-term Outcomes With Planned Multistage Reduced Dose Repeat Stereotactic Radiosurgery for Treatment of Inoperable High-Grade Arteriovenous Malformations: An Observational Retrospective Cohort Study.

Marciscano AE, Huang J, Tamargo RJ, Hu C, Khattab MH, Aggarwal S, Lim M, Redmond KJ, Rigamonti D, Kleinberg LR.

Neurosurgery. 2017 Jul 1;81(1):136-146. doi: 10.1093/neuros/nyw041.

PMID:
28201783
17.

Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology.

Ajani JA, D'Amico TA, Almhanna K, Bentrem DJ, Chao J, Das P, Denlinger CS, Fanta P, Farjah F, Fuchs CS, Gerdes H, Gibson M, Glasgow RE, Hayman JA, Hochwald S, Hofstetter WL, Ilson DH, Jaroszewski D, Johung KL, Keswani RN, Kleinberg LR, Korn WM, Leong S, Linn C, Lockhart AC, Ly QP, Mulcahy MF, Orringer MB, Perry KA, Poultsides GA, Scott WJ, Strong VE, Washington MK, Weksler B, Willett CG, Wright CD, Zelman D, McMillian N, Sundar H.

J Natl Compr Canc Netw. 2016 Oct;14(10):1286-1312.

PMID:
27697982
18.
19.

The strategy of repeat stereotactic radiosurgery without whole brain radiation treatment for new brain metastases: Outcomes and implications for follow-up monitoring.

Shen CJ, Rigamonti D, Redmond KJ, Kummerlowe MN, Lim M, Kleinberg LR.

Pract Radiat Oncol. 2016 Nov - Dec;6(6):409-416. doi: 10.1016/j.prro.2016.04.004. Epub 2016 Apr 26.

PMID:
27687187
20.

Imaging and Clinical Profile Following Concurrent Stereotactic Radiation and Immune Therapy for Melanoma Brain Metastases: Preliminary Results.

Shen C, Lin DD, Redmond KJ, Link K, Kummerlowe M, Douglass J, Lipson EJ, Sharfman W, Bettegowda C, Lim M, Kleinberg LR.

Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2S):E134. doi: 10.1016/j.ijrobp.2016.06.927. No abstract available.

PMID:
27673866
21.

Echoplanar Magnetic Resonance Spectroscopic Imaging Before and Following Radiation Therapy in Patients With High-Grade Glioma.

Lin DD, Lin Y, Link K, Marsman A, Zessler A, Usama SM, Sheriff S, Maudsley AA, Kleinberg LR, Barker PB.

Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2S):E133-E134. doi: 10.1016/j.ijrobp.2016.06.926. No abstract available.

PMID:
27673863
22.

Controversies in the Therapy of Brain Metastases: Shifting Paradigms in an Era of Effective Systemic Therapy and Longer-Term Survivorship.

Shen CJ, Lim M, Kleinberg LR.

Curr Treat Options Oncol. 2016 Sep;17(9):46. doi: 10.1007/s11864-016-0423-3. Review.

PMID:
27447703
23.

BRAF-V600 mutational status affects recurrence patterns of melanoma brain metastasis.

Maxwell R, Garzon-Muvdi T, Lipson EJ, Sharfman WH, Bettegowda C, Redmond KJ, Kleinberg LR, Ye X, Lim M.

Int J Cancer. 2017 Jun 15;140(12):2716-2727. doi: 10.1002/ijc.30241.

24.

Progressive Low-Grade Glioma: Assessment of Prognostic Importance of Histologic Reassessment and MRI Findings.

Narang AK, Chaichana KL, Weingart JD, Redmond KJ, Lim M, Olivi A, Quinones-Hinojosa A, Kleinberg LR.

World Neurosurg. 2017 Mar;99:751-757. doi: 10.1016/j.wneu.2016.04.030. Epub 2016 Apr 19.

PMID:
27108796
25.

Stereotactic Radiosurgery: Treatment of Brain Metastasis Without Interruption of Systemic Therapy.

Shen CJ, Kummerlowe MN, Redmond KJ, Rigamonti D, Lim MK, Kleinberg LR.

Int J Radiat Oncol Biol Phys. 2016 Jun 1;95(2):735-42. doi: 10.1016/j.ijrobp.2016.01.054. Epub 2016 Feb 9.

PMID:
27034175
26.
27.

Reply to C.T. Hiley.

Kleinberg LR.

J Clin Oncol. 2015 Dec 1;33(34):4122-3. doi: 10.1200/JCO.2015.63.2166. Epub 2015 Sep 14. No abstract available.

PMID:
26371132
28.

Prognostic factors associated with pain palliation after spine stereotactic body radiation therapy.

Puvanesarajah V, Lo SL, Aygun N, Liauw JA, Jusué-Torres I, Lina IA, Hadelsberg U, Elder BD, Bydon A, Bettegowda C, Sciubba DM, Wolinsky JP, Rigamonti D, Kleinberg LR, Gokaslan ZL, Witham TF, Redmond KJ, Lim M.

J Neurosurg Spine. 2015 Nov;23(5):620-629. doi: 10.3171/2015.2.SPINE14618. Epub 2015 Jul 31.

29.

Antiangiogenic Therapies and Extracranial Metastasis in Glioblastoma: A Case Report and Review of the Literature.

Khattab MH, Marciscano AE, Lo SS, Lim M, Laterra JJ, Kleinberg LR, Redmond KJ.

Case Rep Oncol Med. 2015;2015:431819. doi: 10.1155/2015/431819. Epub 2015 Jun 23.

30.

Expert Consensus Contouring Guidelines for Intensity Modulated Radiation Therapy in Esophageal and Gastroesophageal Junction Cancer.

Wu AJ, Bosch WR, Chang DT, Hong TS, Jabbour SK, Kleinberg LR, Mamon HJ, Thomas CR Jr, Goodman KA.

Int J Radiat Oncol Biol Phys. 2015 Jul 15;92(4):911-20. doi: 10.1016/j.ijrobp.2015.03.030. Epub 2015 Apr 2.

31.

Esophageal and esophagogastric junction cancers, version 1.2015.

Ajani JA, D'Amico TA, Almhanna K, Bentrem DJ, Besh S, Chao J, Das P, Denlinger C, Fanta P, Fuchs CS, Gerdes H, Glasgow RE, Hayman JA, Hochwald S, Hofstetter WL, Ilson DH, Jaroszewski D, Jasperson K, Keswani RN, Kleinberg LR, Korn WM, Leong S, Lockhart AC, Mulcahy MF, Orringer MB, Posey JA, Poultsides GA, Sasson AR, Scott WJ, Strong VE, Varghese TK Jr, Washington MK, Willett CG, Wright CD, Zelman D, McMillian N, Sundar H; National comprehensive cancer network.

J Natl Compr Canc Netw. 2015 Feb;13(2):194-227.

PMID:
25691612
32.

Gastric cancer, version 2.2013: featured updates to the NCCN Guidelines.

Ajani JA, Bentrem DJ, Besh S, D'Amico TA, Das P, Denlinger C, Fakih MG, Fuchs CS, Gerdes H, Glasgow RE, Hayman JA, Hofstetter WL, Ilson DH, Keswani RN, Kleinberg LR, Korn WM, Lockhart AC, Meredith K, Mulcahy MF, Orringer MB, Posey JA, Sasson AR, Scott WJ, Strong VE, Varghese TK Jr, Warren G, Washington MK, Willett C, Wright CD, McMillian NR, Sundar H; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2013 May 1;11(5):531-46.

PMID:
23667204
33.

Esophageal and esophagogastric junction cancers.

Ajani JA, Barthel JS, Bentrem DJ, D'Amico TA, Das P, Denlinger CS, Fuchs CS, Gerdes H, Glasgow RE, Hayman JA, Hofstetter WL, Ilson DH, Keswani RN, Kleinberg LR, Korn WM, Lockhart AC, Mulcahy MF, Orringer MB, Osarogiagbon RU, Posey JA, Sasson AR, Scott WJ, Shibata S, Strong VE, Varghese TK Jr, Warren G, Washington MK, Willett C, Wright CD; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2011 Aug 1;9(8):830-87. No abstract available.

PMID:
21900218
34.

Genetic variation in DNA-repair pathways and response to radiochemotherapy in esophageal adenocarcinoma: a retrospective cohort study of the Eastern Cooperative Oncology Group.

Yoon HH, Catalano PJ, Murphy KM, Skaar TC, Philips S, Powell M, Montgomery EA, Hafez MJ, Offer SM, Liu G, Meltzer SJ, Wu X, Forastiere AA, Benson AB, Kleinberg LR, Gibson MK.

BMC Cancer. 2011 May 17;11:176. doi: 10.1186/1471-2407-11-176.

35.

Genetic variation in radiation and platinum pathways predicts severe acute radiation toxicity in patients with esophageal adenocarcinoma treated with cisplatin-based preoperative radiochemotherapy: results from the Eastern Cooperative Oncology Group.

Yoon HH, Catalano P, Gibson MK, Skaar TC, Philips S, Montgomery EA, Hafez MJ, Powell M, Liu G, Forastiere AA, Benson AB, Kleinberg LR, Murphy KM.

Cancer Chemother Pharmacol. 2011 Oct;68(4):863-70. doi: 10.1007/s00280-011-1556-5. Epub 2011 Feb 1.

36.

Clinical results of a pilot study on stereovision-guided stereotactic radiotherapy and intensity modulated radiotherapy.

Li S, Kleinberg LR, Rigamonti D, Wharam MD Jr, Rashid A, Jackson J, Djajaputra D, He S, Creasey T, DeWeese TL.

Technol Cancer Res Treat. 2010 Dec;9(6):603-17.

37.

Treatment of pituitary adenomas using radiosurgery and radiotherapy: a single center experience and review of literature.

Sun DQ, Cheng JJ, Frazier JL, Batra S, Wand G, Kleinberg LR, Rigamonti D, Quinones-Hinojosa A, Salvatori R, Lim M.

Neurosurg Rev. 2010 Apr;34(2):181-9. doi: 10.1007/s10143-010-0285-2. Epub 2010 Sep 14.

PMID:
20838838
38.

Gastric cancer.

Ajani JA, Barthel JS, Bekaii-Saab T, Bentrem DJ, D'Amico TA, Das P, Denlinger C, Fuchs CS, Gerdes H, Hayman JA, Hazard L, Hofstetter WL, Ilson DH, Keswani RN, Kleinberg LR, Korn M, Meredith K, Mulcahy MF, Orringer MB, Osarogiagbon RU, Posey JA, Sasson AR, Scott WJ, Shibata S, Strong VE, Washington MK, Willett C, Wood DE, Wright CD, Yang G; NCCN Gastric Cancer Panel.

J Natl Compr Canc Netw. 2010 Apr;8(4):378-409. No abstract available.

PMID:
20410333
39.

The radiosurgical treatment of arteriovenous malformations: obliteration, morbidities, and performance status.

Sun DQ, Carson KA, Raza SM, Batra S, Kleinberg LR, Lim M, Huang J, Rigamonti D.

Int J Radiat Oncol Biol Phys. 2011 Jun 1;80(2):354-61. doi: 10.1016/j.ijrobp.2010.01.049. Epub 2010 Apr 17.

PMID:
20400239
40.

Recurrence after neoadjuvant chemoradiation and surgery for esophageal cancer: does the pattern of recurrence differ for patients with complete response and those with partial or no response?

Meguid RA, Hooker CM, Taylor JT, Kleinberg LR, Cattaneo SM 2nd, Sussman MS, Yang SC, Heitmiller RF, Forastiere AA, Brock MV.

J Thorac Cardiovasc Surg. 2009 Dec;138(6):1309-17. doi: 10.1016/j.jtcvs.2009.07.069.

41.

Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme.

McGirt MJ, Than KD, Weingart JD, Chaichana KL, Attenello FJ, Olivi A, Laterra J, Kleinberg LR, Grossman SA, Brem H, Quiñones-Hinojosa A.

J Neurosurg. 2009 Mar;110(3):583-8. doi: 10.3171/2008.5.17557.

42.

Esophageal cancer.

Ajani JA, Barthel JS, Bekaii-Saab T, Bentrem DJ, D'Amico TA, Fuchs CS, Gerdes H, Hayman JA, Hazard L, Ilson DH, Kleinberg LR, McAleer MF, Meropol NJ, Mulcahy MF, Orringer MB, Osarogiagbon RU, Posey JA, Sasson AR, Scott WJ, Shibata S, Strong VE, Swisher SG, Washington MK, Willett C, Wood DE, Wright CD, Yang G; NCCN Esophageal Cancer Panel.

J Natl Compr Canc Netw. 2008 Oct;6(9):818-49. No abstract available.

PMID:
18926093
43.

Carmustine wafers: localized delivery of chemotherapeutic agents in CNS malignancies.

Lin SH, Kleinberg LR.

Expert Rev Anticancer Ther. 2008 Mar;8(3):343-59. doi: 10.1586/14737140.8.3.343. Review.

PMID:
18366283
44.

Repeat stereotactic radiosurgery for high-grade and large intracranial arteriovenous malformations.

Raza SM, Jabbour S, Thai QA, Pradilla G, Kleinberg LR, Wharam M, Rigamonti D.

Surg Neurol. 2007 Jul;68(1):24-34; discussion 34.

PMID:
17586215
45.

ABT-888, an orally active poly(ADP-ribose) polymerase inhibitor that potentiates DNA-damaging agents in preclinical tumor models.

Donawho CK, Luo Y, Luo Y, Penning TD, Bauch JL, Bouska JJ, Bontcheva-Diaz VD, Cox BF, DeWeese TL, Dillehay LE, Ferguson DC, Ghoreishi-Haack NS, Grimm DR, Guan R, Han EK, Holley-Shanks RR, Hristov B, Idler KB, Jarvis K, Johnson EF, Kleinberg LR, Klinghofer V, Lasko LM, Liu X, Marsh KC, McGonigal TP, Meulbroek JA, Olson AM, Palma JP, Rodriguez LE, Shi Y, Stavropoulos JA, Tsurutani AC, Zhu GD, Rosenberg SH, Giranda VL, Frost DJ.

Clin Cancer Res. 2007 May 1;13(9):2728-37.

46.

Clinical course and pathologic findings after Gliadel and radiotherapy for newly diagnosed malignant glioma: implications for patient management.

Kleinberg LR, Weingart J, Burger P, Carson K, Grossman SA, Li K, Olivi A, Wharam MD, Brem H.

Cancer Invest. 2004;22(1):1-9.

PMID:
15069758

Supplemental Content

Loading ...
Support Center